A detailed history of Stone House Investment Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Stone House Investment Management, LLC holds 432 shares of NVO stock, worth $45,476. This represents 0.01% of its overall portfolio holdings.

Number of Shares
432
Previous 432 -0.0%
Holding current value
$45,476
Previous $61,000 16.39%
% of portfolio
0.01%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $3,778 - $5,029
37 Added 9.37%
432 $55,000
Q4 2023

Jan 30, 2024

BUY
$87.78 - $105.45 $3,511 - $4,218
40 Added 11.27%
395 $40,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $16,187 - $35,518
178 Added 100.56%
355 $32,000
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $9,826 - $10,876
63 Added 55.26%
177 $28,000
Q1 2023

Apr 25, 2023

BUY
$132.34 - $159.14 $15,086 - $18,141
114 New
114 $18,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stone House Investment Management, LLC Portfolio

Follow Stone House Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone House Investment Management, LLC with notifications on news.